Diagnosis A doctor will carry out a physical examination and enquire about Any ongoing medical history. If the patient has symptoms, or if a routine blood test shows abnormally high PSA levels, further examinations may be requested. Imaging scans can show and track the presence of prostate cancer. Imaging scans can show and track the presence of prostate cancer. Tests may include: a digital rectal examination (DRE), in which a doctor will manually check for any Stage 1 prostate cancer treatment abnormalities of the prostate with their finger a biomarker test checking the blood, urine, or body tissues of a person with cancer for chemicals unique to individuals stage 1 prostate cancer treatment stage 1 prostate cancer treatment with cancer If these tests show abnormal results, further tests will include: a stage 1 prostate cancer treatment PCA3 test examining the urine for the PCA3 gene only found in prostate cancer cells a transrectal ultrasound scan providing imaging of stage 1 prostate cancer treatment the affected region using a probe that emits sounds a biopsy, or the removal of 12 to 14 small pieces of tissue from several areas of the stage 1 prostate cancer treatment Stage 1 prostate cancer treatment prostate for examination under a microscope These will help confirm the stage of the cancer, whether it has spread, and what treatment is appropriate. To track any spread, or metastasis, doctors may use a bone, CT scan, or MRI scan.
Outlook If the disease Stage 1 prostate cancer treatment stage 1 prostate cancer treatment is found before it spreads stage 1 prostate cancer treatment to other organs in a process known as metastasis, the 5-year survival rate is 99 percent. Once the cancer metastasizes, or spreads, the 5-year survival rate is 29 percent. Regular screening can help detect prostate cancer while it is still treatable. Risk factors The exact cause of prostate cancer is unclear, but there are many possible risk factors. Age Prostate cancer is stage 1 prostate cancer treatment rare among men under the age of 45 years, but more common after Stage 1 prostate cancer treatment the age of 50 years.
Geography Stage 1 prostate cancer treatment Prostate cancer occurs most frequently in North America, northwestern Europe, on the stage 1 prostate cancer treatment Caribbean Islands, and in stage 1 prostate cancer treatment Australia. Genetic factors Certain genetic and ethnic groups have an increased risk of prostate cancer. In the U. S., prostate cancer is at least 60 percent more common and 2 to 3 times more deadly among black men than non-Hispanic white men.
A man also has a much higher risk of developing cancer if his identical twin has it, and a man whose brother or father had stage 1 prostate cancer treatment prostate cancer has twice the risk of developing it compared to other men.
Having Stage 1 prostate cancer treatment a brother who has or has had prostate cancer is more of a genetic risk than having a father with the disease.
Prostate cancer treatment gold markers
Prostate cancer stage 1 treatment
Adenoma prostatico g2
| 02.12.2017 - crazy |
| Non-surgical options, too years with haematuria or undergoing checkup smoking Smoking has been. |
| 02.12.2017 - MANAX_666 |
| Spread to the bones and results have slow growing With nonaggressive prostate cancer, the tumor either. |
No comments:
Post a Comment